We are live on ! Find out more
EVM

Evelyn V. Moreno Portfolio holdings

AUM $212M
1-Year Est. Return 31.13%
This Fund
S&P 500
This Quarter Est. Return
-15.95%
1 Year Est. Return
+31.13%
3 Year Est. Return
+39.44%
5 Year Est. Return
+122.36%
10 Year Est. Return
+222.57%
AUM
$429M
AUM Growth
-$65.3M
Cap. Flow
+$22.7M
Cap. Flow %
5.3%
Top 10 Hldgs %
35.52%
Holding
165
New
56
Increased
37
Reduced
36
Closed
7

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.07M
2
AMZN icon
Amazon
AMZN
+$2.59M
3
NKE icon
Nike
NKE
+$1.39M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26M
5
COST icon
Costco
COST
+$1.07M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$2.98M
2
CVS icon
CVS Health
CVS
+$2.7M
3
PYPL icon
PayPal
PYPL
+$2.26M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$1.77M
5
AAPL icon
Apple
AAPL
+$1.2M

Sector Composition

Rank Sector Weight
1 Technology 23.09%
2 Healthcare 13.91%
3 Financials 13.27%
4 Communication Services 8.73%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
51
Costco
COST
$422B
$2.49M 0.58%
5,202
+2,119
+69% +$1.07M
LOW icon
52
Lowe's Companies
LOW
$117B
$2.22M 0.52%
12,703
-454
-3% -$87.5K
BRK.A icon
53
Berkshire Hathaway Class A
BRK.A
$1.1T
$2.04M 0.48%
5
+2
+67% +$942K
ABT icon
54
Abbott
ABT
$183B
$1.5M 0.35%
13,840
+9,280
+204% +$1.05M
ORCL icon
55
Oracle
ORCL
$374B
$1.47M 0.34%
21,033
+9,960
+90% +$729K
ZTS icon
56
Zoetis
ZTS
$32.4B
$1.43M 0.33%
8,335
+3,254
+64% +$563K
JNJ icon
57
Johnson & Johnson
JNJ
$618B
$1.06M 0.25%
5,971
+1,225
+26% +$218K
ABBV icon
58
AbbVie
ABBV
$443B
$1.02M 0.24%
6,686
+4,100
+159% +$626K
DEO icon
59
Diageo
DEO
$49B
$1.02M 0.24%
5,853
+1,723
+42% +$328K
CE icon
60
Celanese
CE
$4.9B
$938K 0.22%
7,975
+3,530
+79% +$507K
GWW icon
61
W.W. Grainger
GWW
$65.3B
$932K 0.22%
2,050
ADP icon
62
Automatic Data Processing
ADP
$106B
$836K 0.2%
3,980
+1,094
+38% +$240K
CPRT icon
63
Copart
CPRT
$27B
$835K 0.19%
30,756
+21,352
+227% +$608K
KLAC icon
64
KLA
KLAC
$239B
$819K 0.19%
25,660
+14,980
+140% +$504K
LLY icon
65
Eli Lilly
LLY
$1.02T
$772K 0.18%
2,381
+220
+10% +$66K
CSCO icon
66
Cisco
CSCO
$457B
$744K 0.17%
17,460
+12,815
+276% +$613K
ALC icon
67
Alcon
ALC
$33.6B
$735K 0.17%
+10,521
New +$768K
DG icon
68
Dollar General
DG
$28B
$726K 0.17%
2,958
+1,654
+127% +$386K
AJG icon
69
Arthur J. Gallagher & Co
AJG
$64.1B
$722K 0.17%
+4,426
New +$735K
EEM icon
70
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$713K 0.17%
17,770
-5,250
-23% -$220K
LIN icon
71
Linde
LIN
$221B
$661K 0.15%
+2,298
New +$718K
BG icon
72
Bunge Global
BG
$20.4B
$635K 0.15%
+7,000
New +$777K
TSLA icon
73
Tesla
TSLA
$1.23T
$623K 0.15%
2,775
ELV icon
74
Elevance Health
ELV
$81.5B
$603K 0.14%
+1,249
New +$618K
PGR icon
75
Progressive
PGR
$123B
$596K 0.14%
+5,123
New +$581K

Similar funds

Evelyn V. Moreno's Q2 2022 Portfolio in Review

As of Q2 2022, Evelyn V. Moreno held 165 positions worth $429M, down 13% from $494M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Evelyn V. Moreno deployed $22.7M of net new capital in Q2 2022, opening 56 new positions and adding to 37 existing holdings. Its largest new stake was Bunge Global: 7,000 shares worth $635K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $2.98M trimmed.

  • Evelyn V. Moreno's largest Q2 2022 buy was Bunge Global: 7,000 shares worth $635K.
  • Evelyn V. Moreno added most to Bristol-Myers Squibb in Q2 2022, an estimated $5.07M increase.
  • Evelyn V. Moreno's biggest Q2 2022 reduction was Novartis, cutting an estimated $2.98M.
  • Evelyn V. Moreno fully exited SVB Financial Group in Q2 2022, selling an estimated $272K.
  • Evelyn V. Moreno's ten largest holdings make up 36% of its $429M portfolio in Q2 2022.
  • Evelyn V. Moreno opened 56 new positions and closed 7 in Q2 2022.
  • Evelyn V. Moreno's portfolio value fell 13% quarter-over-quarter to $429M.

Based on Evelyn V. Moreno's 13F filing for Q2 2022, filed 11 Aug 2022.